Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity.
about
Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptorActivating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2Molecular recognition of BMP-2 and BMP receptor IABone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptorsBMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-IID-glucuronyl C5-epimerase acts in dorso-ventral axis formation in zebrafishExtracellular distribution of diffusible growth factors controlled by heparan sulfate proteoglycans during mammalian embryogenesisCan heparins stimulate bone cancer stem cells and interfere with tumorigenesis?Biomaterial delivery of morphogens to mimic the natural healing cascade in boneThe clip-segment of the von Willebrand domain 1 of the BMP modulator protein Crossveinless 2 is preformedIsolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP-2Identification of the ligand-binding site of the BMP type IA receptor for BMP-4Activin and bone morphogenetic proteins are present in perinatal sensory neuron target tissues that induce neuropeptidesRestriction of BMP4 activity domains in the developing neural tube of the mouse embryo.Cell-surface heparan sulfate proteoglycans potentiate chordin antagonism of bone morphogenetic protein signaling and are necessary for cellular uptake of chordinScaffold design for bone regenerationRenal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferaseSurface Modification of Titanium with BMP-2/GDF-5 by a Heparin Linker and Its Efficacy as a Dental ImplantTuning cellular responses to BMP-2 with material surfacesStructure of Gremlin-1 and analysis of its interaction with BMP-2Engineering anisotropic biomimetic fibrocartilage microenvironment by bioprinting mesenchymal stem cells in nanoliter gel dropletsHeparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerizationBMP signals promote proepicardial protrusion necessary for recruitment of coronary vessel and epicardial progenitors to the heartGrowth Differentiation Factor 5-Mediated Enhancement of Chondrocyte Phenotype Is Inhibited by Heparin: Implications for the Use of Heparin in the Clinic and in Tissue Engineering Applications.Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration.The elusive functions of proteoglycans: in vivo veritasHeparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2Conditional ablation of the heparan sulfate-synthesizing enzyme Ext1 leads to dysregulation of bone morphogenic protein signaling and severe skeletal defects.Repair of experimentally induced large osteochondral defects in rabbit knee with various concentrations of Escherichia coli-derived recombinant human bone morphogenetic protein-2Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathwaysBioactive coatings for orthopaedic implants-recent trends in development of implant coatings.Inkjet-based biopatterning of bone morphogenetic protein-2 to spatially control calvarial bone formation.WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signalingA sulfated nanofibrous mesh supporting the osteogenic differentiation of periosteum-derived cells.Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis.Perlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro.Growth factor delivery for bone tissue engineering.Growth factor delivery-based tissue engineering: general approaches and a review of recent developmentsNovel osteoinductive photo-cross-linkable chitosan-lactide-fibrinogen hydrogels enhance bone regeneration in critical size segmental bone defectsExperimental and computational investigation of the effect of hydrophobicity on aggregation and osteoinductive potential of BMP-2-derived peptide in a hydrogel matrix
P2860
Q24290737-8DAC239F-2829-4C31-9849-8B993C0E956BQ24318483-49A62F27-51F9-41A4-887F-45515A5ABD8AQ24324472-1B4C03C4-8314-447F-914B-08F21BA110ECQ24548576-ED8E6399-8290-4B4B-A810-924D2A9971C2Q24631766-EDD8E484-B8AF-4950-871E-FD46476C6240Q24816968-78BB13BF-724F-4D5B-AD29-5F0F188324EAQ26851937-BFA1E94C-9DD8-4EFF-B79B-9E154B4F6B52Q26852760-A06758CC-B1D6-4D68-B31C-00FC2F285326Q26996479-C1471E52-8237-4979-A532-561515164E22Q27686823-5DBEE289-02A5-4C1E-BCB8-82D02702A635Q28145537-EE87F58F-1134-4FA8-A806-DEEF82281EB3Q28203953-7C8FB2BF-AFCD-4BAC-824A-DE80DECAE396Q28214552-1E794982-4780-4DE4-A797-C24C264137FCQ28508366-79E998B1-ABAC-4E18-A5A0-D1EDBA7A5218Q28512603-6CD553E9-2BCC-4A36-AE70-EE0CD7716B54Q28538144-B9ADAA32-3B19-402C-B018-CC85408F98DCQ28589603-BD61689B-E97C-493D-B835-059A1B0507E5Q28817120-32287821-B8AC-44DD-8E02-347AA2CE8945Q28831008-7016CE3C-66BD-43EE-B7FA-1B89EFA99BADQ30090218-3F8367A5-784D-4555-A8A4-0EC74EDB1AA8Q30419471-D8DEF00D-EE6B-499D-A956-3641A2224E7CQ30433400-8B9CD063-DA31-44CB-ABA9-31B61B5174A5Q30496194-53932920-F2AD-4EDE-87D7-30BA07C8E411Q33580590-2835BC2D-29B9-4F27-ADA0-C84736ABED22Q33639409-0DA604DF-B415-4107-A883-6497E87CE5D4Q33825069-A63B05A3-DF6D-4245-8F79-D30809C99801Q33887551-4CFFD1EA-F54D-4B9F-83A8-A31F3F0C34E9Q33911298-73C23140-2857-42A1-95AA-8DC66EF6FF05Q33990177-238B2457-D160-4F15-AFD7-E2D0C8557AF0Q34003880-C8BC1698-6866-4720-AD2D-E1A1E3947A79Q34072309-F4094AC5-97F2-4739-B629-91E209E9B462Q34185985-4711FF1C-D132-4864-8899-79DCB36BEF09Q34186700-109EBFA8-405A-4C4A-890D-6194C82E098EQ34323750-FBC03C25-F237-4C72-BF4C-14746C380B72Q34411156-FE6B43BF-FA6E-46F1-B803-91D354509E36Q34419440-756C5DD2-C54A-4659-900D-EB5D24591EE9Q34513981-991A4E8C-A263-49A2-AA82-51C247C6A240Q34548765-53578DD1-B3C6-424B-BE3E-C2EA7F94F06AQ34614886-2DAEC61D-3575-4765-996C-C4A73E2DCC6FQ34941544-4FDC901D-7914-48D9-ADFE-9164F462BAC7
P2860
Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Human bone morphogenetic prote ...... ifies its biological activity.
@en
type
label
Human bone morphogenetic prote ...... ifies its biological activity.
@en
prefLabel
Human bone morphogenetic prote ...... ifies its biological activity.
@en
P2093
P1433
P1476
Human bone morphogenetic prote ...... ifies its biological activity.
@en
P2093
P304
P356
10.1111/J.1432-1033.1996.0295N.X
P407
P577
1996-04-01T00:00:00Z